Brief: Neuren Pharmaceuticals Acadia Expand Global Partnership For Trofinetide
14/07/2023 02:12
July 14 (Reuters) - Neuren Pharmaceuticals Ltd NEU.AX :
* NEUREN AND ACADIA EXPAND GLOBAL PARTNERSHIP FOR
TROFINETIDE
* NEUREN AND ACADIA EXPAND GLOBAL PARTNERSHIP FOR
TROFINETIDE
* NEUREN AND ACADIA EXPAND GLOBAL PARTNERSHIP FOR
TROFINETIDE
* U NEUREN TO RECEIVE US$100 MILLION UP-FRONT, PLUS
ADDITIONAL
POTENTIAL MILESTONE PAYMENTS OF UP TO US$427 MILLION, PLUS
ROYALTIES
Source text for Eikon: ID:nASX9pY93
Further company coverage: NEU.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuren Pharmaceuticals
See all newsAustralia's Neuren set for weekly gain on FDA nod, drug forecast upgrade
Australia's Neuren Pharmaceuticals gains on upbeat FY trofinetide earnings outlook
Australia's Neuren Pharma rises as US FDA grants orphan tag for NNZ-2591
Strong partner sales propel Neuren Pharmaceuticals to top of Australia benchmark
Brief: Neuren Pharmaceuticals Says DAYBU Recommended For Approval In European Union